NexGel, Inc. (NASDAQ:NXGL – Get Free Report) CEO Brian Joseph Kieser purchased 133,216 shares of NexGel stock in a transaction on Tuesday, November 10th. The stock was bought at an average cost of $5.50 per share, with a total value of $732,688.00. Following the completion of the acquisition, the chief executive officer owned 133,216 shares in the company, valued at approximately $732,688. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.
NexGel Stock Performance
NASDAQ NXGL opened at $3.88 on Monday. The company’s fifty day moving average is $4.51 and its two-hundred day moving average is $11.31. NexGel, Inc. has a 52-week low of $3.00 and a 52-week high of $41.20. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.43 and a quick ratio of 0.27. The firm has a market capitalization of $1.90 million, a price-to-earnings ratio of -0.27 and a beta of 0.81.
NexGel (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings results on Saturday, November 14th. The company reported ($2.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.80) by $2.52. NexGel had a negative net margin of 51.26% and a negative return on equity of 121.18%. The firm had revenue of $3.18 million for the quarter, compared to analyst estimates of $4.19 million. Equities research analysts forecast that NexGel, Inc. will post -18.80 EPS for the current year.
Hedge Funds Weigh In On NexGel
An institutional investor recently bought a new position in NexGel stock. Empery Asset Management LP bought a new position in shares of NexGel, Inc. (NASDAQ:NXGL – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 90,000 shares of the company’s stock, valued at approximately $3,474,000. Empery Asset Management LP owned approximately 0.98% of NexGel at the end of the most recent quarter. Institutional investors and hedge funds own 2.21% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on NXGL shares. Maxim Group downgraded shares of NexGel from a “buy” rating to a “hold” rating in a research note on Monday, August 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of NexGel in a report on Friday, October 9th. Finally, Zacks Research upgraded shares of NexGel to a “hold” rating in a research report on Friday, October 2nd. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $40.00.
Check Out Our Latest Research Report on NXGL
NexGel Company Profile
NexGel, Inc. (NASDAQ:NXGL) develops and manufactures high-water-content hydrogel products for medical, consumer and other specialized applications. The company uses proprietary formulations and electron-beam processing to produce flexible, skin-compatible products designed to retain moisture and provide cooling, cushioning or conductive properties. Its product applications include wound care, burn and surgical care, pain management, medical diagnostics and personal wellness. NexGel supplies hydrogel sheets, patches and related components used in products such as wound dressings, therapeutic pads and medical electrodes.
Featured Articles
- Five stocks we like better than NexGel
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
